
<!DOCTYPE html>
<!--[if lt IE 8]>      <html class="no-js nav theme-green lt-ie10 lt-ie9 lt-ie8  " lang="en-us"> <![endif]-->
<!--[if IE 8]>         <html class="no-js nav theme-green lt-ie10 lt-ie9  " lang="en-us"> <![endif]-->
<!--[if IE 9]>         <html class="no-js nav theme-green lt-ie10  " lang="en-us"> <![endif]-->
<!--[if !IE]><!-->     <html class="no-js nav theme-green  " lang="en-us" > <!--<![endif]-->	
    <head>
        <meta charset="utf-8" />
                <title>CDC - Childhood Lead Poisoning Prevention Program - PLPYC 91 Chapter 7</title>
        		
        <meta name="description" content="The Childhood Lead Poisoning Prevention Program is committed to the Healthy People goal of eliminating elevated blood lead levels in children by 2020. CDC continues to assist state and local childhood lead poisoning   prevention programs, to provide a scientific basis for policy decisions, and to ensure that health issues are addressed in decisions about housing and the environment." />        <meta name="keywords" content="CDC Lead Poisoning Prevention Branch,lead,blood lead level,childhood lead poisoning,LPPB,lead funding,surveillance,lead hazard,toxicity,chelation,lead testing,screening,risk assessment,lead and pregnancy,lead data,lead case management,lead in homes" />		<meta name="viewport" content="width=device-width, initial-scale=1" />
		        <link rel="apple-touch-icon-precomposed" sizes="144x144" href="../../../../../TemplatePackage/3.0/images/cdc-touch-icon-144x144.png" />
        <link rel="apple-touch-icon-precomposed" sizes="114x114" href="../../../../../TemplatePackage/3.0/images/cdc-touch-icon-114x114.png" />
        <link rel="apple-touch-icon-precomposed" sizes="72x72" href="../../../../../TemplatePackage/3.0/images/cdc-touch-icon-72x72.png" />
        <link rel="apple-touch-icon-precomposed" href="../../../../../TemplatePackage/3.0/images/cdc-touch-icon-57x57.png" />
        <link rel="shortcut icon" href="../../../../../TemplatePackage/3.0/images/favicon.ico" />	
		
		<meta name="robots" content="index,follow" />
		<meta property="cdc:template_version" content="3.0" />
		<meta property="cdc:content-id" content="293053"/>
		<meta property="cdc:revision-id" content="11"/>
								<!-- Internal Release Version # 3.6.3 -->
                			<link rel="stylesheet" href="../../../../../TemplatePackage/3.0/css/lib/bootstrap24.css" />
	<link rel="stylesheet" href="../../../../../TemplatePackage/3.0/css/app.css@3.2.1.7.css" />
	<!--[if gt IE 9]><!--><!--<![endif]-->
	<!--[if IE 7]>
		<link rel="stylesheet" href="/TemplatePackage/3.0/css/lib/font-awesome-ie7.css" />
	<![endif]-->
	<!--[if lt IE 9]>
		<link rel="stylesheet" href="/TemplatePackage/3.0/css/ie.css" />
	<![endif]-->
	<link rel="stylesheet" media="print" href="../../../../../TemplatePackage/3.0/css/print.css@3.2.1.7.css" />
	<script src="../../../../../TemplatePackage/3.0/js/libs/modernizr-latest.js"></script>
	<script>
		if(!Date.now){Date.now=function now(){return new Date().getTime()}}
		var page_timing = page_timing || {};
		page_timing.page_start = Date.now();
		function $$(e){if(window.$){e()}else{setTimeout(function(){$$(e)},50)}}
		// (function(){function e(e,t){var n=e.length;while(n--){if(e[n].indexOf(t)>-1){return e[n]}}return false}var t=e(document.getElementsByTagName("html")[0].className.split(" "),"theme-");if(t){var n=document.createElement("link");n.rel="stylesheet";n.type="text/css";n.media="screen";n.href="/TemplatePackage/3.0/css/themes/"+t+".css";document.getElementsByTagName("head")[0].appendChild(n)}})();

		var settings = {}, addthis = null;
	</script>

	<meta name="application-name" content="CDC.gov"/>
	<meta property="cdc:template_version" content="3.2.1.7" />
	<meta name="msapplication-TileColor" content="#0061aa" />
	<meta name="msapplication-square70x70logo" content="/TemplatePackage/3.0/images/Win8_tile_70x70.png" />
	<meta name="msapplication-square150x150logo" content="/TemplatePackage/3.0/images/Win8_tile_150x150.png" />
	<meta name="msapplication-wide310x150logo" content="/TemplatePackage/3.0/images/Win8_tile_310x150.png" />
	<meta name="msapplication-square310x310logo" content="/TemplatePackage/3.0/images/Win8_tile_310x310.png" />
	<meta name="viewport" content="width=device-width,initial-scale=1,shrink-to-fit=no">		        



        <meta name="DC.Creator" content="National Center for Environmental Health"> <style type="text/css">  </style>         
	<link rel="stylesheet" type="text/css" href="https://www.cdc.gov/migration/iteration4/nceh/local/css/local.css"/>
  		    </head>
    <body>
				



				<div id="skipmenu">
	<a href="chapter7.htm#searchTarget" class="skippy">Skip directly to search</a>
	<a href="chapter7.htm#azTab" class="skippy">Skip directly to A to Z list</a>
	<a href="chapter7.htm#nav-container" class="skippy">Skip directly to navigation</a>
	<a href="chapter7.htm#share-bar" class="skippy">Skip directly to page options</a>
	<a href="chapter7.htm#contentArea" class="skippy">Skip directly to site content</a>
</div>		    	<div id="wrapper">
    		
<!-- references to this removed intentionally -->
    		<header id="header">
    			<div class="container">
                    <div class="row">
                    	<div id="logo" class="span14">
                    		<!--iPad touch response and 508 voice reader issue currently under investigation -->
<a href="../../../../../index.html" title="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People">
	<img src="../../../../../TemplatePackage/3.0/images/masthead_subpage.svg" alt="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People" class="hidden-one" />
	<img src="../../../../../TemplatePackage/3.0/images/masthead_1-col.svg" alt="Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People" class="visible-one" />
</a>

<!-- IOS9 iPad bug work around - make sure screen readers have a readable version of the logo to read
<a class="tp-sr-only" href="https://www.cdc.gov">Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People</a>
 -->
                    	</div>
                    	<!-- search -->
                    	<div id="searchArea" class="span10 hidden-one hidden-two">							
							
<div class="hidden"><a href="chapter7.htm#" name="searchTarget">Start of Search Controls</a></div>
<form class="searchForm" method="get" action="https://search.cdc.gov/search">
	<fieldset class="search-form-wrapper ">
		<legend>Search Form Controls</legend>
		<div class="search-form-checkbox">
			<label class="subset"><input type="checkbox" name="subset" checked="checked" value="">Search The CDC</label>
		</div>
		<div class="search-input-wrapper">
			<div class="search-buttons">
				<button class="btn-clear"><span class="sprite-14-close">Cancel</span></button>
				<button class="btn-submit"><span class="sprite-14-search-black">Submit</span></button>
				<input type="submit" value="Submit" style="display:none; visibility:hidden;" /> 
			</div>
			<div class="search-input">
				<label><input type="text" placeholder="SEARCH" name="query" /><span class="hidden">Search The CDC</span></label>
			</div>
		</div>
		<input type="hidden" name="utf8" value="&#x2713;" />
					<input type="hidden" name="affiliate" value="cdc-main" />
			</fieldset>
</form>							<div class="a2z-button pull-right hidden-one hidden-two"><a href="chapter7.htm#" id="azTab">CDC A-Z Index <span class="icon-angle-down"></span></a></div>
                    	</div>
                    </div>
                    	<div class="hidden-three hidden-four" id="mobile-menu">
		<ul>
			<li id="vp1-menu-button" class="border-bottom-white"><a href="chapter7.htm#" id="menu-nav"><span class="sprite-16-menu"></span>MENU</a></li>
			<li id="vp1-a2z-button" class="border-bottom-white"><a href="chapter7.htm#" id="menu-az">CDC A-Z</a></li>
			<li id="vp1-search-button" class="border-bottom-white"><a href="chapter7.htm#" id="menu-search"><span class="sprite-16-search-white"></span>SEARCH</a></li>
		</ul>
	</div>
<script>if (typeof page_timing !== 'undefined') { page_timing.menu_load = Date.now(); }</script>
                    <div class="a2z-bar hide">
                    	<div>
	<ul>
		<li><a href="../../../../../az/a.html">A</a></li>
		<li><a href="../../../../../az/b.html">B</a></li>
		<li><a href="../../../../../az/c.html">C</a></li>
		<li><a href="../../../../../az/d.html">D</a></li>
		<li><a href="../../../../../az/e.html">E</a></li>
		<li><a href="../../../../../az/f.html">F</a></li>
		<li><a href="../../../../../az/g.html">G</a></li>
		<li><a href="../../../../../az/h.html">H</a></li>
		<li><a href="../../../../../az/i.html">I</a></li>
		<li><a href="../../../../../az/j.html">J</a></li>
		<li><a href="../../../../../az/k.html">K</a></li>
		<li><a href="../../../../../az/l.html">L</a></li>
		<li><a href="../../../../../az/m.html">M</a></li>
		<li><a href="../../../../../az/n.html">N</a></li>
		<li><a href="../../../../../az/o.html">O</a></li>
		<li><a href="../../../../../az/p.html">P</a></li>
		<li><a href="../../../../../az/q.html">Q</a></li>
		<li><a href="../../../../../az/r.html">R</a></li>
		<li><a href="../../../../../az/s.html">S</a></li>
		<li><a href="../../../../../az/t.html">T</a></li>
		<li><a href="../../../../../az/u.html">U</a></li>
		<li><a href="../../../../../az/v.html">V</a></li>
		<li><a href="../../../../../az/w.html">W</a></li>
		<li><a href="../../../../../az/x.html">X</a></li>
		<li><a href="../../../../../az/y.html">Y</a></li>
		<li><a href="../../../../../az/z.html">Z</a></li>
		<li><a href="../../../../../az/0.html">#</a></li>
	</ul>
</div>
<script>if (typeof page_timing !== 'undefined') { page_timing.a2z_load = Date.now(); }</script>                    </div>
                    <div id="searchArea-two-column" class="span24 searchbar hide hidden-three hidden-four">
						  
<div class="hidden"><a href="chapter7.htm#" name="searchTarget">Start of Search Controls</a></div>
<form class="searchForm" method="get" action="https://search.cdc.gov/search">
	<fieldset class="search-form-wrapper ">
		<legend>Search Form Controls</legend>
		<div class="search-form-checkbox">
			<label class="subset"><input type="checkbox" name="subset" checked="checked" value="">Search The CDC</label>
		</div>
		<div class="search-input-wrapper">
			<div class="search-buttons">
				<button class="btn-clear"><span class="sprite-14-close">Cancel</span></button>
				<button class="btn-submit"><span class="sprite-14-search-black">Submit</span></button>
				<input type="submit" value="Submit" style="display:none; visibility:hidden;" /> 
			</div>
			<div class="search-input">
				<label><input type="text" placeholder="SEARCH" name="query" /><span class="hidden">Search The CDC</span></label>
			</div>
		</div>
		<input type="hidden" name="utf8" value="&#x2713;" />
					<input type="hidden" name="affiliate" value="cdc-main" />
			</fieldset>
</form>					</div>
                    <!--
	See the noscript include for modifying the emergency message. DO NOT add it here.
-->
<script>if (typeof page_timing !== 'undefined') { page_timing.emergency_load = Date.now(); }</script>
    				<div class="titlebar">
    					<h2>


<a href="../../../default.htm">Lead</a>

</h2>
    				</div>
    				<!-- emergency -->
<div id="emergencyContainer">
	<!--
	<div class="alert alert-error en">
		<b>Attention!</b> Uncomment this section and place the emergency message here.
	</div>
	<div class="alert alert-error esp">
		<b>&#161;Atenci&#243;n!</b> Elimine el comentario de esta secci&#243;n y colocar el mensaje de emergencia aqu&#237;.
	</div>	
	-->
</div>

<!-- no script -->
<noscript>
	<div class="alert alert-block"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../../../../other/about_cdcgov.html">About CDC.gov</a>.</div>
</noscript>
<script>if (typeof page_timing !== 'undefined') { page_timing.noscript_load = Date.now(); }</script>
     			</div>
    		</header>
    		<div class="container">				
                <div id="content">
					<div class="row">
        				<!-- left nav -->
        				<div id="nav-container" class="hidden-one hidden-two span5">
    						<nav id="left" class="hidden-one hidden-two">
    							



<h3><a href="../../../default.htm">Lead Home</a></h3>

<ul id="nav-primary">
<li><a href="../../../calendar.htm">Calendar of Events</a>
<ul>
<li><a href="../../../nlppw.htm">National Lead Poisoning Prevention Week</a>
<ul>
<li><a href="../../../nlppw_archive.htm">Archived Materials</a></li>
</ul>
</li>
</ul>
</li>

<li><a href="../../../about/program.htm">CDC's Childhood Lead Poisoning Prevention Program</a>
<ul>
<li><a href="../../../acclpp/acclpp_main.htm">Advisory Committee (ACCLPP)</a>
<ul>
<li><a href="../../../acclpp/activities.htm">Current Activities</a>
<ul>
<li><a href="../../../acclpp/blood_lead_levelwg.htm">Blood Lead Level of Concern Workgroup</a></li>

<li><a href="../../../acclpp/educationwg.htm">Educational Interventions for Lead-Exposed Children Work Group</a></li>

<li><a href="../../../acclpp/laboratorywg.htm">Laboratory Work Group</a></li>

<li><a href="../../../acclpp/productswg.htm">Lead in Consumer Products Work Group</a></li>

<li><a href="../../../acclpp/pregnancywg.htm">Lead and Pregnancy Work Group</a></li>
</ul>
</li>

<li><a href="../../../acclpp/meetings/meetings.htm">Meetings, Agendas, and Minutes</a></li>
</ul>
</li>

<li><a href="../../../acclpp/blood_lead_levels.htm">New Blood Lead Level Information</a></li>

<li><a href="../../../funding.htm">Funding Information</a></li>

<li><a href="../../../leadinwater/default.htm">Lead in Drinking Water</a>
<ul>
<li><a href="../../../waterlines.htm">Lead-based Water Lines</a></li>

<li><a href="../../../blood_levels.htm">Washington, D.C. Blood Lead Level Tests</a></li>

<li><a href="../../../leadinwater/reanalysis.htm">Effect of Previously Missing Blood Lead Level (BPb) Surveillance Data</a></li>
</ul>
</li>
</ul>
</li>

<li><a href="../../../data/index.htm">Data, Statistics, &#38; Surveillance</a>
<ul>
<li><a href="../../../data/national.htm">CDC's National Surveillance Data</a></li>

<li><a href="../../../data/state.htm">CDC's State Surveillance Data</a></li>

<li><a href="../../../data/learnmore.htm">Learn More about CDCâ€™s Childhood Lead Poisoning Data</a></li>

<li><a href="../../../data/definitions.htm">Definitions</a></li>

<li><a href="../../../data/hhlpss.htm">HHLPSS: Healthy Homes and Lead Poisoning Surveillance System</a></li>

<li><a href="../../../data/quarterly.htm">Protocol for Quarterly Data Submission</a></li>

<li><a href="../../../data/survobjectives.htm">Surveillance Objectives</a></li>
</ul>
</li>

<li><a href="../../../training/harvard/index.htm">HSPH Program Evaluation Course</a>
<ul>
<li><a href="../../../training/harvard/2009/table.htm">2009</a>
<ul>
<li><a href="../../../training/harvard/2009/alabama.htm">Alabama</a></li>

<li><a href="../../../training/harvard/2009/baltimore.htm">Baltimore</a></li>

<li><a href="../../../training/harvard/2009/columbus.htm">Columbus</a></li>

<li><a href="../../../training/harvard/2009/connecticut.htm">Connecticut</a></li>

<li><a href="../../../training/harvard/2009/deleware.htm">Delaware</a></li>

<li><a href="../../../training/harvard/2009/kansascity.htm">Kansas City</a></li>

<li><a href="../../../training/harvard/2009/kent.htm">Kent County</a></li>

<li><a href="../../../training/harvard/2009/miami_faith.htm">Miami: Faith-Based</a></li>

<li><a href="../../../training/harvard/2009/miami_start.htm">Miami: Healthy Start</a></li>

<li><a href="../../../training/harvard/2009/mississippi.htm">Mississippi</a></li>

<li><a href="../../../training/harvard/2009/nevada.htm">Nevada</a></li>

<li><a href="../../../training/harvard/2009/tennessee.htm">Tennessee</a></li>
</ul>
</li>

<li><a href="../../../training/harvard/2008/table.htm">2008</a>
<ul>
<li><a href="../../../training/harvard/2008/al.htm">Alabama</a></li>

<li><a href="../../../training/harvard/2008/boston.htm">Boston</a></li>

<li><a href="../../../training/harvard/2008/ga.htm">Georgia</a></li>

<li><a href="../../../training/harvard/2008/il.htm">Illinois</a></li>

<li><a href="../../../training/harvard/2008/liberia.htm">Liberia</a></li>

<li><a href="../../../training/harvard/2008/mn.htm">Minnesota</a></li>

<li><a href="../../../training/harvard/2008/nc.htm">North Carolina</a></li>

<li><a href="../../../training/harvard/2008/phila.htm">Philadelphia</a></li>

<li><a href="../../../training/harvard/2008/tn.htm">Tennessee</a></li>

<li><a href="../../../training/harvard/2008/vt.htm">Vermont</a></li>

<li><a href="../../../training/harvard/2008/wi.htm">Wisconsin</a></li>
</ul>
</li>
</ul>
</li>

<li><a href="../../../parents.htm">Information for Parents</a></li>

<li><a href="../../../partners.htm">Partners</a></li>

<li><a href="../../../policy.htm">Policy Resources</a></li>

<li><a href="../../../tips.htm">Prevention Tips</a>
<ul>
<li><a href="../../../tips/populations.htm">At Risk Populations</a>
<ul>
<li><a href="../../../tips/pregnant.htm">Pregnant Women</a></li>

<li><a href="../../../tips/adoption.htm">International Adoption</a></li>

<li><a href="../../../tips/refugees.htm">Refugees</a></li>
</ul>
</li>

<li><a href="../../../tips/sources.htm">Sources of Lead</a>
<ul>
<li><a href="../../../tips/artificialturf.htm">Artificial Turf</a></li>

<li><a href="../../../tips/candy.htm">Candy</a></li>

<li><a href="../../../tips/folkmedicine.htm">Folk Medicine</a></li>

<li><a href="../../../tips/sindoor.htm">Sindoor Alert</a></li>

<li><a href="../../../tips/jewelry.htm">Toy Jewelry</a></li>

<li><a href="../../../tips/toys.htm">Toys</a></li>

<li><a href="../../../tips/water.htm">Water</a></li>
</ul>
</li>
</ul>
</li>

<li><a href="../../default.htm">Publications</a>
<ul>
<li><a href="../../../casemanagement/casemanage_main.htm">Case Management</a>
<ul>
<li><a href="../../../casemanagement/qa_cm.htm">Questions and Answers</a></li>
</ul>
</li>

<li><a href="../../screening.htm">Screening Young Children for Lead Poisoning</a>
<ul>
<li><a href="../../1997/backgr.htm">Backgrounder</a></li>

<li><a href="../../1997/factlead.htm">Facts on Lead</a></li>

<li><a href="../../1997/factguid.htm">Facts on New CDC Guidance</a></li>

<li><a href="../../1997/q_a.htm">Questions and Answers</a></li>

<li><a href="../../1997/quotes.htm">Quotes</a></li>

<li><a href="../../1997/pr970221.htm">HHS Press Release</a></li>
</ul>
</li>

<li><a href="contents.htm">Preventing Lead Poisoning in Young Children (1991)</a>
<ul>
<li><a href="chapter1.htm">Chapter 1</a></li>

<li><a href="chapter2.htm">Chapter 2</a></li>

<li><a href="chapter3.htm">Chapter 3</a></li>

<li><a href="chapter4.htm">Chapter 4</a></li>

<li><a href="chapter5.htm">Chapter 5</a></li>

<li><a href="chapter6.htm">Chapter 6</a></li>

<li><a href="chapter7.htm">Chapter 7</a></li>

<li><a href="chapter8.htm">Chapter 8</a></li>

<li><a href="chapter9.htm">Chapter 9</a></li>

<li><a href="appendix1.htm">Appendix I</a></li>

<li><a href="appendix2.htm">Appendix II</a></li>

<li><a href="tables.htm">Tables</a></li>

<li><a href="figures.htm">Figures</a></li>
</ul>
</li>
</ul>
</li>

<li><a href="../../../programs/default.htm">State Programs</a>
<ul>
<li><a href="../../../programs/al.htm">Alabama</a></li>

<li><a href="../../../programs/ak.htm">Alaska</a></li>

<li><a href="../../../programs/az.htm">Arizona</a></li>

<li><a href="../../../programs/ar.htm">Arkansas</a></li>

<li><a href="../../../programs/ca.htm">California</a></li>

<li><a href="../../../programs/chicago.htm">Chicago</a></li>

<li><a href="../../../programs/co.htm">Colorado</a></li>

<li><a href="../../../programs/ct.htm">Connecticut</a></li>

<li><a href="../../../programs/de.htm">Delaware</a></li>

<li><a href="../../../programs/dc.htm">District of Columbia</a></li>

<li><a href="../../../programs/fl.htm">Florida</a></li>

<li><a href="../../../programs/ga.htm">Georgia</a></li>

<li><a href="../../../programs/hi.htm">Hawaii</a></li>

<li><a href="../../../programs/houston.htm">Houston</a></li>

<li><a href="../../../programs/id.htm">Idaho</a></li>

<li><a href="../../../programs/il.htm">Illinois</a></li>

<li><a href="../../../programs/in.htm">Indiana</a></li>

<li><a href="../../../programs/ia.htm">Iowa</a></li>

<li><a href="../../../programs/ks.htm">Kansas</a></li>

<li><a href="../../../programs/ky.htm">Kentucky</a></li>

<li><a href="../../../programs/losangeles.htm">Los Angeles</a></li>

<li><a href="../../../programs/la.htm">Louisiana</a></li>

<li><a href="../../../programs/me.htm">Maine</a></li>

<li><a href="../../../programs/md.htm">Maryland</a></li>

<li><a href="../../../programs/ma.htm">Massachusetts</a></li>

<li><a href="../../../programs/mi.htm">Michigan</a></li>

<li><a href="../../../programs/mn.htm">Minnesota</a></li>

<li><a href="../../../programs/ms.htm">Mississippi</a></li>

<li><a href="../../../programs/mo.htm">Missouri</a></li>

<li><a href="../../../programs/mt.htm">Montana</a></li>

<li><a href="../../../programs/ne.htm">Nebraska</a></li>

<li><a href="../../../programs/nv.htm">Nevada</a></li>

<li><a href="../../../programs/nh.htm">New Hampshire</a></li>

<li><a href="../../../programs/nj.htm">New Jersey</a></li>

<li><a href="../../../programs/nm.htm">New Mexico</a></li>

<li><a href="../../../programs/ny.htm">New York</a></li>

<li><a href="../../../programs/newyorkcity.htm">New York City</a></li>

<li><a href="../../../programs/nc.htm">North Carolina</a></li>

<li><a href="../../../programs/nd.htm">North Dakota</a></li>

<li><a href="../../../programs/oh.htm">Ohio</a></li>

<li><a href="../../../programs/ok.htm">Oklahoma</a></li>

<li><a href="../../../programs/or.htm">Oregon</a></li>

<li><a href="../../../programs/pa.htm">Pennsylvania</a></li>

<li><a href="../../../programs/philadelphia.htm">Philadelphia</a></li>

<li><a href="../../../programs/ri.htm">Rhode Island</a></li>

<li><a href="../../../programs/sc.htm">South Carolina</a></li>

<li><a href="../../../programs/sd.htm">South Dakota</a></li>

<li><a href="../../../programs/tn.htm">Tennessee</a></li>

<li><a href="../../../programs/tx.htm">Texas</a></li>

<li><a href="../../../programs/ut.htm">Utah</a></li>

<li><a href="../../../programs/vt.htm">Vermont</a></li>

<li><a href="../../../programs/va.htm">Virginia</a></li>

<li><a href="../../../programs/wa.htm">Washington</a></li>

<li><a href="../../../programs/wv.htm">West Virginia</a></li>

<li><a href="../../../programs/wi.htm">Wisconsin</a></li>

<li><a href="../../../programs/wy.htm">Wyoming</a></li>
</ul>
</li>

<li><a href="../../../toolstraining.htm">Tools and Training</a>
<ul>
<li><a href="../../../tools/cap.htm">CLPPP CAP</a></li>

<li><a href="../../../tools/assessement_tools.htm">Healthy Homes Assessment Tools</a></li>

<li><a href="../../../tools/leadliteracy.htm">Lead Health Literacy Initiative</a></li>

<li><a href="../../refugeetoolkit/refugee_tool_kit.htm">Refugee Tool Kit</a>
<ul>
<li><a href="../../refugeetoolkit/rtk_resources.htm">Resources</a></li>
</ul>
</li>

<li><a href="../../../training/lpptc.htm">Healthy Homes and Lead Poisoning Prevention Training Center (HHLPPTC)</a>
<ul>
<li><a href="../../../training/lpptctracks.htm">Training Tracks</a></li>
</ul>
</li>
</ul>
</li>
</ul>


    						</nav>
    						<div class="nav-related">
							

<!-- <div class="module-typeG emailupdates"><span class="sprite-24-govd-icon"></span><h4>Get Email Updates</h4><p>To receive email updates about this page, enter your email address:</p><form name="govdelivery" action="https://public.govdelivery.com/accounts/USCDC/subscribers/qualify"><fieldset><label><span class="hidden">Enter Email Address</span><input type="text" class="email" name="email" value="" onfocus="this.value=''" /></label><a class="explain" href="http://www.cdc.gov/emailupdates/">What's this?</a><a href="javascript:quicksubscribe();return false;" class="button">Submit</a><noscript><a class="explain" href="http://www.cdc.gov/emailupdates/">What's this?</a><label><span class="hidden">Submit Button</span><input type="submit" class="button submit" name="commit" value="Submit" /></label></noscript></fieldset></form></div> -->

    						

<!-- EMPTY SSI -->

							



							</div>    						    				
        				</div>
        				<div id="featureArea">
    						<div class="span19">
    							



    						</div>
        				</div>						
    					<div class="breadcrumbs hidden-one span19">
    						

<div class="bread-crumb hidden-one"></div>

    					</div>
						<div class="span19 pagetitle">	
    						    							<div class='syndicate'>
    						    						    							<div class='mSyndicate'>
    																					<h1>Preventing Lead Poisoning in Young Children: Chapter 7</h1>
															    						    							</div>
    						    						    							</div>
    												</div>
						<div id="share-bar" class="span19">		
    						<div class="socialmediabar">
								<div class="row">
            						<div class="hidden-one pull-right">
        								            							            							            						</div>	
    								<div class="span8">
    									<div id="socialMediaShareContainer">
	<div class="share_container noLinking">
	 	<a class="share_button_facebook" title="Facebook" href="chapter7.htm#"><span class="tp-sr-only">Recommend on Facebook</span><span id="share_facebook" class="facebookRecommend"> </span></a>
	 	<a class="share_button_twitter" title="Twitter" href="chapter7.htm#"><span class="tp-sr-only">Tweet</span><span id="share_twitter" class="twitterTweet"> </span></a>
		<a class="share_button" href="chapter7.htm#socialMediaShareContainer" ><img src="../../../../../TemplatePackage/3.0/images/social/addthis-32.png" alt="Share" /><span class="shareButtonEn tp-sr-only" aria-label="Share">Share</span><span class="shareButtonEs tp-sr-only" aria-label="Compartir">Compartir</span></a>
	</div>
</div>

<!-- target anchor for return to top feature in VP1 -->
<a id="content-start" tabindex="-1"></a>
    								</div>
								</div>
    						</div>
    					</div>	
    					<!-- body -->
    					<div id="body" class="span19">
    						<div id="contentArea" >								
        						        																						        						                                                                                            					            						<div class='syndicate'>
            					            					            						<div class='mSyndicate'>
            					            					        							<ul><li><a href="contents.htm#contents">Table of Contents</a></li><li><a href="https://www.cdc.gov/nceh/lead/publications/books/plpyc/Chapter1.htm">Chapter 1. Introduction</a></li><li><a href="https://www.cdc.gov/nceh/lead/publications/books/plpyc/Chapter2.htm" target="_self">Chapter 2. Background</a></li><li><a href="https://www.cdc.gov/nceh/lead/publications/books/plpyc/Chapter3.htm" target="_self">Chapter 3. Sources and Pathways of Lead Exposure</a></li><li><a href="https://www.cdc.gov/nceh/lead/publications/books/plpyc/Chapter4.htm" target="_self">Chapter 4. The Role of the Pediatric Health-Care Provider</a></li><li><a href="https://www.cdc.gov/nceh/lead/publications/books/plpyc/Chapter5.htm" target="_self">Chapter 5. The Role of State and Local Public Agencies</a></li><li><a href="https://www.cdc.gov/nceh/lead/publications/books/plpyc/Chapter6.htm" target="_self">Chapter 6. Screening</a></li><li><a href="https://www.cdc.gov/nceh/lead/publications/books/plpyc/Chapter7.htm" target="_self">Chapter 7. Diagnostic Evaluation and Medical Management of Children with Blood Lead Levels &gt; or = to 20 &#181;g/dL</a> <ul><li><a href="chapter7.htm#Summary">Summary</a></li><li><a href="chapter7.htm#Symptoms">Symptoms of Lead Poisoning</a></li><li><a href="chapter7.htm#Evaluation">Evaluation of the Child with a Blood Lead Level &gt; or = to 20 &#181;g/dL</a></li><li><a href="chapter7.htm#Pharmacology">Pharmacology of Chelating Agents</a></li><li><a href="chapter7.htm#Treatment guidelines">Treatment Guidelines for Children with Blood Lead Levels &gt; or = to 20 &#181;g/dL</a></li><li><a href="chapter7.htm#followup">Post-chelation Followup</a></li><li><a href="chapter7.htm#Research areas">Research Areas and Future Trends in the Management of Childhood Lead Poisoning</a></li><li><a href="chapter7.htm#References">References</a></li></ul></li><li><a href="https://www.cdc.gov/nceh/lead/publications/books/plpyc/Chapter8.htm" target="_self">Chapter 8. Management of Lead Hazards in the Environment of the Individual Child</a></li><li><a href="https://www.cdc.gov/nceh/lead/publications/books/plpyc/Chapter9.htm" target="_self">Chapter 9. Management of Lead Hazards in the Community</a></li><li><a href="https://www.cdc.gov/nceh/lead/publications/books/plpyc/Appendix1.htm" target="_self">Appendix I. Capillary Sampling Protocol</a></li><li><a href="https://www.cdc.gov/nceh/lead/publications/books/plpyc/Appendix2.htm" target="_self">Appendix II. Summary for the Pediatric Health-Care Provider</a></li><li><a href="tables.htm" target="_self">Tables</a></li><li><a href="figures.htm" target="_self">Figures</a></li></ul><br /><hr /><span class="toTop"><em class="icon-angle-up"><!-- --></em>&#160;<a href="chapter7.htm#">Top of Page</a></span> <h2><a id="Chapter 7" name="Chapter 7"></a>Chapter 7. Diagnostic Evaluation and Medical Management of Children with Blood Lead Levels &gt; or = to 20 &#181;g/dL</h2><h3><a id="Summary" name="Summary"></a>Summary</h3><br /><div style=" margin-left: 5%; margin-right: 5%; padding: 6px; border: 1px solid black; margin-bottom: 6px;"><p><em>Children with blood lead levels &gt; or = to 20 &#181;g/dL need complete medical evaluations.</em></p><p><em>Several pharmacologic agents can reduce blood lead levels; however, the most important factor is reducing the child&#39;s exposure to lead.</em></p><p><em>Research and new developments may change many aspects of the medical management of poisoned children.</em></p></div><p>Children with blood lead levels between 10 &#181;g/dL and 19 &#181;g/dL and their siblings need followup and repeat screening as described in previous Chapters. They do not, however, need medical evaluation as described in this Chapter.</p><p>The cornerstones of clinical management are careful clinical and laboratory surveillance of the child, medical treatment when indicated, and eradication of controllable sources of environmental lead. <strong>The most important factor in case management is to reduce the child&#39;s exposure to lead.</strong></p><p>All children with confirmed venous blood lead levels &gt; or = to 20 &#181;g/dL require medical evaluation. The urgency of further medical evaluation depends on the blood lead level and whether symptoms are present.</p><p>The decision to institute medical management should virtually always be made on the basis of a venous blood lead measurement. No other screening test can be considered diagnostic. If the first evaluation was made on capillary blood, a confirmatory venous blood lead level must be done. Even if the first diagnostic measurement was on venous blood, it is preferable to retest before starting chelation therapy. For children with blood lead levels &gt; or = to 70 &#181;g/dL or clinical symptoms of lead poisoning, chelation should not be postponed while awaiting results of the repeat test.</p><hr /><span class="toTop"><em class="icon-angle-up"><!-- --></em>&#160;<a href="chapter7.htm#">Top of Page</a></span> <h3><a id="Symptoms" name="Symptoms"></a>Symptoms of Lead Poisoning</h3><br /><div style=" margin-left: 5%; margin-right: 5%; padding: 6px; border: 1px solid black; margin-bottom: 6px;"><center>Symptomatic lead poisoning is a medical emergency.</center></div><p><strong>Symptoms of lead poisoning in a child with an elevated blood lead level constitute a medical emergency, and the child should be hospitalized.</strong> Symptoms, which can mimic several other pediatric disorders, must be looked for so they are not missed (Piomelli et al.,1984).</p><p>Acute lead encephalopathy is characterized by some or all of these symptoms: coma, seizures, bizarre behavior, ataxia, apathy, incoordination, vomiting, alteration in the state of consciousness, and subtle loss of recently acquired skills. Any one or a mixture of these symptoms, associated with an elevated blood lead level, is an acute medical emergency. Lead encephalopathy is almost always associated with a blood lead level exceeding 100 &#181;g/dL, although, occasionally, it has been reported at blood lead levels as low as 70 &#181;g/dL. Even when identified and promptly treated, severe and permanent brain damage may result in 70%-80% of children with lead encephalopathy (Perlstein and Attala, 1966). Children with symptomatic lead poisoning with or without encephalopathy represent an acute medical emergency. <strong>The possibility of lead encephaliopathy should be considered in the differential diagnosis of children presenting with coma and convulsions of unknown etiology.</strong></p><p>Except for coma and seizures, symptomatic lead poisoning without encephalopathy is characterized by symptoms similar to those of lead encephalopathy. Symptomatic lead poisoning without encephalopathy is characterized by one or a combination of these symptoms: decrease in play activity, lethargy, anorexia, sporadic vomiting, intermittent abdominal pain, and constipation. These symptoms are usually associated with a blood lead levels of at least 70 &#181;g/dL, although occasionally cases have been associated with levels as low as 50 &#181;g/dL. If the blood lead level is below 50 &#181;g/dL, other causes of the symptoms should be sought. <strong>Since acute lead encephalopathy may develop in any symptomatic child, treatment and supportive measures must be started immediately on an emergency basis.</strong></p><hr /><span class="toTop"><em class="icon-angle-up"><!-- --></em>&#160;<a href="chapter7.htm#">Top of Page</a></span> <h3><a id="Evaluation" name="Evaluation"></a>Evaluation of the Child with a Blood Lead Level &gt; or = to 20 &#181;g/dL</h3><br /><div style=" margin-left: 5%; margin-right: 5%; padding: 6px; border: 1px solid black; margin-bottom: 6px;"><p>Take a careful history and do a physical examination.</p><p>Include evaluation of the child&#39;s iron status and other special diagnostic tests.</p></div><h4>History and Physical Examination</h4><br /><p>A child with a blood lead level &gt; or = to 20 &#181;g/dL should have a pediatric evaluation, whether or not symptoms are present.</p><p>Special attention should be given to:</p><ol><li>A detailed history, including the presence or absence of clinical symptoms, child&#39;s mouthing activities, the existence of pica, nutritional status (especially iron and calcium intake), dietary habits, family history of lead poisoning, potential sources of lead exposure (including exposure due to home renovation), and previous blood lead measurements.</li><li>Detailed environmental and occupational histories of adults in the household or other places the child spends a lot of time.</li><li>The physical examination, with particular attention to the neurologic examination and psychosocial and language development. A neurobehavioral assessment may be useful in children receiving chelation therapy both at the time of diagnosis and as the child approaches school age. Findings of language delay or other problems can prompt referral to appropriate programs.</li><li>Evaluation of iron status using measurement of iron and total iron binding capacity or of ferritin.</li></ol><br /> <a id="ironstatus" name="ironstatus"></a> <h4>Iron Status and Special Tests</h4><br /><ol><li><p><strong><em>Tests for Iron Deficiency</em></strong><br /><strong>Because iron deficiency can enhance lead absorption and toxicity and often coexists with it, all children with blood lead levels &gt; or = to 20 &#181;g/dL should be tested for iron deficiency.</strong> Measurements of hemoglobin, hematocrit, and reticulocyte are not adequately sensitive, and erythrocyte Protoporphyrin (EP) is not specific enough to diagnose iron deficiency (although EP can be used to screen for iron deficiency).</p><p><strong>Serum iron and iron binding capacity (transferrin saturation) and ferritin</strong> are the most sensitive indicators of iron status. An abnormally low ratio of serum iron to iron binding capacity (transferrin saturation) of 0.2 is consistent with iron deficiency. The serum ferritin level, however, is the most definitive and accurate indication of overall iron status, although it is an acute phase reactant and may be falsely elevated in sick children; a value &lt; or = to 12 &#181;g/dL indicates iron deficiency. Although all iron deficient children should receive treatment for this condition, the treatment should not be started until after chelation is completed in children receiving dimercaprol (BAL).</p></li><li><p><strong><em>EP Level</em></strong><br />An elevated EP level indicates impairment of the heme biosynthetic pathway. EP levels are sensitive screening tests for iron deficiency, and iron status should be assessed in any child with an elevated EP level (that is, &gt; or = to 35 &#181;g/dL when standardized using 241 L cm-1 mmol-1, &gt; or = to 28 &#181;g/dL when standardized using 297 L cm-1 mmol-1, or &gt; or = to 70 &#181;mol/mol when measured in &#181;mol/mol units).</p><p>Because EP levels take about 2 weeks to increase, EP levels may provide an indication of the duration of lead exposure (Chisolm, 1982; Chisolm, personal communication). Similarly, monitoring the EP level after medical and environmental interventions for poisoned children may be useful. If exposure to lead has ceased, EP values elevated because of lead poisoning decline slowly over several weeks or months (Piomelli et al., 1984). A progressive decline in EP concentrations indicates that combined medical and environmental case management is proceeding efficaciously.</p> <a id="ChelationTest" name="ChelationTest"></a></li><li><p><strong>Edetate Disodium Calcium (CaNa<sub>2</sub>EDTA) Provocative Chelation Test</strong><br />The mobilization test is used to determine whether a child with an initial confirmatory blood lead level of 25 to 44 &#181;g/dL will respond to chelation therapy with a brisk lead diuresis (Piomelli et al., 1984; Markowitz and Rosen, 1991). Because of the cost and staff time needed for quantitative urine collection, this test is used only in selected medical centers where large numbers of lead-poisoned children are treated. Children whose blood lead levels are &gt; or = to 45 &#181;g/dL should not receive a provocative chelation test; they should be referred for appropriate chelation therapy immediately.</p><p>The outcome of the provocative chelation test is determined not by a decrease in the blood lead level but by the amount of lead excreted per dose of CaNa<sub>2</sub>EDTA given. This ratio correlates well with blood lead levels. In one study, almost all children with blood lead levels 45 &#181;g/dL had positive provocative tests, 76% of the children with blood lead levels 35 to 44 &#181;g/dL had positive test results, and 35% of the children with blood lead levels 25 to 34 &#181;g/dL had positive test results (Markowitz and Rosen, 1991). This test should not be done until the child is iron replete, since iron status may affect the outcome of the test (Markowitz et al., 1990).</p><p><strong>Conducting a CaNa<sub>2</sub>EDTA Provocative Chelation test.</strong> First, a repeated baseline blood lead level must be obtained. The patient is asked to empty the bladder, and then CaNa<sub>2</sub>EDTA is administered at a dose of 500 mg/m<sup>2</sup> in 5% dextrose infused <strong>over 1 hour</strong>. (A somewhat painful but practical alternative is to administer intramuscularly the same dose mixed with procaine so that the final concentration of procaine is 0.5%.) All urine must be collected with lead-free equipment over the next 8 hours. (An 8 hour mobilization test has been shown to be as reliable as a 24-hour mobilization test (Markowitz and Rosen, 1984).) An 8-hour test can be accomplished on an out-patient basis, but the patient should not leave the clinic during this test.) In the laboratory, the urine volume should be carefully measured and stored at 20&#176;C until the lead concentration is measured. Extreme care must be taken to ensure that lead-free equipment is used.</p><p>The use of lead-free apparatus for urine collection is mandatory. Special lead-free collection apparatus must be used if valid test results are to be obtained. The laboratory that will perform the analysis should supply the proper collection apparatus. Preferably, urine should be voided directly into polyethylene or polypropylene bottles that have been cleaned by the usual procedures, then washed in nitric acid, and thoroughly rinsed with deionized, distilled water. For children who are not toilet trained, plastic pediatric urine collectors can be used. Urine collected in this manner should be transferred directly to the urine collection bottles.</p><p><strong>Interpretation of a CaNa<sub>2</sub>EDTA Provocative Chelation Test.</strong> To obtain the total lead excretion in micrograms, the concentration of lead in the urine (in micrograms per milliliter) is multiplied by the total urinary volume (in milliliters). The total urinary excretion of lead (micrograms) is divided by the amount of CaNa<sub>2</sub>EDTA given (milligrams) to obtain the lead excretion ratio:</p><p>&#160;</p><center>Lead excreted (&#181;g)<br /><div style=" padding-bottom: 6px;">__________________</div>CaNa <sub>2</sub>EDTA given (mg)</center><br /><p>An 8-hour CaNa<sub>2</sub>EDTA chelation provocative test is considered positive if the lead excretion ratio is &gt; 0.6 (Markowitz and Rosen, 1991). Some clinicians use a cutoff of 0.5 for the lead excretion ratio (Weinberger et al., 1987). Children with blood lead levels 25 to 44 &#181;g/dL and positive chelation test results should undergo a 5-day course of chelation.</p><p>Regardless of age, all children with elevated blood lead values and negative provocative chelation results should have blood lead levels measured monthly. If the elevation in blood lead values persists, the CaNa<sub>2</sub>EDTA provocative test can be repeated every 1 to 3 months and interpreted according to the above guidelines.</p></li><li><p><strong><em>Radiologic Examination of the Abdomen</em></strong><br />Radiologic examination of the abdomen (flat plate) may show radiopaque foreign material if the material has been ingested during the preceding 24 to 36 hours. Neither negative nor positive x-ray results are diagnostic or definitive. A flat plate of the abdomen may, however, provide information about the source of lead if paint chips or other lead objects are found.</p></li><li><p><strong><em>Radiologic Examination of the Long Bones</em></strong><br />X-rays of the long bones are unreliable for diagnosing acute lead poisoning, and they should not be obtained on a routine basis. They may provide some indication of whether lead poisoning has occurred in the past or has been ongoing for a length of time, and this may occasionally be important. Lines of increased density in the metaphyseal plate of the distal femur, proximal tibia, and fibula may be caused by lead which has disrupted the metabolism of bone matrix. Although these lines are sometimes called lead lines, they are areas of increased mineralization or calcification and not x-ray shadows of deposited lead.</p><p>The following tests are <strong>NOT</strong> indicated for the diagnosis or clinical management of lead poisoning:</p><ol style=" list-style: inherit;"><li><p><strong><em>Microscopic Examination of Red Cells for Basophilic Stippling</em></strong><br />Since basophilic stippling is not always found in severe lead poisoning and is insensitive to lesser degrees of lead poisoning, it is not useful in diagnosis.</p></li><li><p><strong><em>Tests of Hair and Fingerprints for Lead Levels</em></strong><br />The levels of lead in hair or fingernails do not correlate well with blood lead levels, except in extreme cases of symptomatic lead poisoning; therefore, these tests are not useful in diagnosis. Children should never receive chelating agents on the basis of analyses of lead levels in hair or fingernails.</p></li></ol></li></ol><hr /><span class="toTop"><em class="icon-angle-up"><!-- --></em>&#160;<a href="chapter7.htm#">Top of Page</a></span> <h3><a id="Pharmacology" name="Pharmacology"></a>Pharmacology of Chelating Agents</h3><br /><p><a href="tables.htm#Table 7-1">Table 7-1</a> Several drugs are used in the treatment of lead poisoning. These drugs, capable of binding or chelating lead, deplete the soft and hard (skeletal) tissues of lead and thus reduce its acute toxicity (Chisolm, 1968; Markowitz and Rosen, 1984; Piomelli et al., 1984; Rosen et al., in press). All drugs have potential side effects and must be used with caution (Piomelli et al., 1984). The basic pharmacologic characteristics of the various drugs are described below.</p><h4><a id="Bal" name="Bal"></a>BAL</h4><br /><p><strong><em>Mechanism of action</em></strong>. Two molecules of dimercaprol (BAL) combine with one atom of heavy metal to form a stable complex. BAL enhances fecal and urinary excretion of lead and diffuses well into erythrocytes. Because it is predominantly excreted in bile, BAL can be administered in the presence of renal impairment (Chisolm, 1968).</p><p><strong><em>Route of administration and dosage</em></strong>. BAL is available only in peanut oil for intramuscular administration. It is usually given every 4 hours, although it may be given every 8 hours; dosages are discussed in <a href="chapter7.htm#Treatment guidelines">Treatment Guidelines for Children with Blood Lead Levels &gt; or = to 20 &#181;g/dL</a>.</p><p><strong><em>Precautions and toxicity.</em></strong> For patients with glucose-6-phosphate dehydrogenase deficiency (G-6-PD), some clinicians recommend that BAL should be used only in life-threatening situations because it may induce hemolysis. Medicinal iron should never be administered during BAL therapy, because the combination of iron and BAL has been implicated in serious reactions. If iron deficiency coexists, it should not be treated until after BAL therapy has been completed. In cases of extreme anemia, blood transfusions are preferable.</p><p>Between 30% and 50% of patients who receive BAL will experience side effects. Mild febrile reactions and transient elevations of hepatic transaminase may be observed. Other minor adverse effects include, in order of frequency, nausea and occasional vomiting, headache, mild conjunctivitis, lacrimation, rhinorrhea, and salivation. Most side effects are transient and rapidly subside as the drug is metabolized and excreted. Intravenous hydration coupled with restricting oral intake can circumvent, in large part, gastrointestinal distress.</p><p><strong>BAL should not be used for children who are allergic to peanuts or peanut products.</strong></p><hr /><span class="toTop"><em class="icon-angle-up"><!-- --></em>&#160;<a href="chapter7.htm#">Top of Page</a></span> <h4><a id="CaNa&lt;sub&gt;2&lt;/sub&gt;edta" name="CaNa&lt;sub&gt;2&lt;/sub&gt;edta"></a>CaNa<sub>2</sub>EDTA</h4><br /><p><em>Only CaNa<sub>2</sub>EDTA can be used for treating children with lead poisoning. Na<sub>2</sub>EDTA (disodium edetate) should never be used for treating children with lead poisoning because it will induce tetany and possibly fatal hypocalcaemia.</em></p><p><strong><em>Mechanism of action.</em></strong> CaNa<sub>2</sub>EDTA increases urinary lead excretion twentyfold to fiftyfold. CaNa<sub>2</sub>EDTA removes lead from the extra cellular compartment only, because it does not enter cells (Osterloh and Becker, 1986).</p><p><strong><em>Route of administration and dosage.</em></strong> The preferred route for administration of CaNa<sub>2</sub>EDTA is intravenous. CaNa<sub>2</sub>EDTA must be diluted to a concentration of &lt;0.5% either in dextrose and water or in 0.9% saline solution. It can be given as a continuous infusion or it can be given in two divided doses a day through a heparin lock over 30 to 60 minutes. CaNa<sub>2</sub>EDTA causes extreme pain when administered intramuscularly; therefore, when given by this route, it should be mixed with procaine so that the final concentration of procaine is 0.5%. CaNa<sub>2</sub>EDTA should never be given orally because it enhances absorption of lead from the gastrointestinal tract.</p><p>Dosages vary by situation and are detailed in <a href="chapter7.htm#Treatment guidelines">Treatment Guidelines for Children with Blood Lead Levels &gt; or = 20